Trang kết quả 11 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1012)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (738)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (12)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2611)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2611)
Công nghệ sinh học (2611)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2611)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1705)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (553)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (419)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (501)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Viracta Therapeutics VIRX | $0.02 — |
-12.2
|
$715.4K — | $7.43K — | $0.02 — | $0.02 — | $715.4K — | 0 | -$1.1 — | |
| Syros Pharmaceuticals SYRS | $0.02 — |
+0.41
|
$652.03K — | $33.36K — | $0.02 — | $0.02999 — | $652.03K — | 0 | -$3.07 — | |
| LIDDS AB (publ) LIDDS.ST | $0.05 0.0046 USD |
-1.25
|
$6.47M 631.39K USD | $385.86K 37.67K USD | $0.05 0.0046 USD | $0.05 0.0048 USD | $6.47M 631.39K USD | 0 | -$0.04 -0.003 USD | |
| Theralink THER | $0.0001 — |
0
|
$615.15K — | $10.1K — | $0.0001 — | $0.0001 — | $615.15K — | 0 | $0 — | |
| Neutra NTRR | $0.0002 — |
0
|
$583.58K — | $7.2M — | $0.0002 — | $0.0002 — | $583.58K — | 0 | $0 — | |
| Hepion Pharmaceuticals, Inc. HEPA | $0.4899 — |
+18.98
|
$526.82K — | $84.32M — | $0.4099 — | $0.7399 — | $526.82K — | 0 | -$220 — | |
| Oxurion NV OXUR.BR | $0.1 0.11 USD |
-7.51
|
$468.1K 511.7K USD | $67.19K 73.45K USD | $0.1 0.11 USD | $0.11 0.12 USD | $468.1K 511.7K USD | 0.0010 | $97.53 106.61 USD | |
| Bonus BioGroup Ltd. BONS.TA | $14.7 0.04 USD |
-1.34
|
$174.02M 507.44K USD | $278.95K 813.41 USD | $14.5 0.04 USD | $15.2 0.04 USD | $174.02M 507.44K USD | 0 | -$0.04 -0.0001 USD | |
| Wesana Health WSNAF | $0.02 — |
-24.14
|
$460.25K — | $8.25K — | $0.02999 — | $0.02999 — | $460.25K — | 0 | -$0.02 — | |
| NanoSphere Health Sciences Inc. NSHS.CN | $0.05999 0.04 USD |
0
|
$616.51K 457.49K USD | $0 0 USD | $0 0 USD | $0 0 USD | $616.51K 457.49K USD | 0 | -$0.01 -0.007 USD | |
| RespireRx Pharmaceuticals RSPI | $0.0008 — |
0
|
$377.39K — | $75.81K — | $0.002 — | $0.002299 — | $377.39K — | 0 | -$0.02 — | |
| Kiromic BioPharma KRBP | $0.1199 — |
0
|
$318.42K — | $42.93K — | $0.1799 — | $0.3099 — | $318.42K — | 0 | -$3.17 — | |
| Amarantus BioScience AMBS | $0.0005 — |
0
|
$315.2K — | $100.1K — | $0.0001 — | $0.0001 — | $315.2K — | 0 | -$0.04 — | |
| CNBX Pharmaceuticals CNBX | $0.01 — |
0
|
$311.11K — | $28.11K — | $0.007599 — | $0.007599 — | $311.11K — | 0 | -$0.02 — | |
| TransCode Therapeutics RNAZ | $0.38 — |
-1.68
|
$265.62K — | $1.88M — | $0.3499 — | $0.39 — | $265.62K — | 0.000068 | $5.57K — | |
| Scandion Oncology A/S SCOL.ST | $0.01 0.0010 USD |
-1.75
|
$2.63M 256.66K USD | $1M 97.81K USD | $0.0097 0.00094 USD | $0.01 0.0011 USD | $2.63M 256.66K USD | 0 | -$0.24 -0.02 USD | |
| GlobeStar Therapeutics GSTC | $0.0002 — |
0
|
$248.22K — | $5.56K — | $0.0002 — | $0.0002 — | $248.22K — | 0 | $0 — | |
| Mera Pharmaceuticals MRPI | $0.0001 — |
0
|
$222.92K — | $4.42M — | $0.0001 — | $0.0001 — | $222.92K — | 0 | $0 — | |
| Endonovo Therapeutics ENDV | $0.0002 — |
0
|
$219.58K — | $14.49M — | $0.0002 — | $0.0002 — | $219.58K — | 0 | $0 — | |
| GB Sciences GBLX | $0.0004 — |
0
|
$162.83K — | $1K — | $0.0002999 — | $0.0002999 — | $162.83K — | 0 | $0 — | |
| BioLineRx Ltd. BLRX.TA | $1.6 0.0046 USD |
-5.88
|
$37.95M 110.67K USD | $27.16M 79.19K USD | $1.4 0.0040 USD | $1.7 0.0049 USD | $37.95M 110.67K USD | 0 | -$0.04 -0.0001 USD | |
| Innovation Pharmaceuticals IPIX | $0.0002 — |
0
|
$103.67K — | $72K — | $0.0002 — | $0.0002 — | $103.67K — | 0 | -$0.01 — | |
| Can-Fite BioPharma Ltd. CANF.TA | $1.8 0.0052 USD |
0
|
$32.92M 96K USD | $3.48M 10.15K USD | $1.7 0.0049 USD | $1.9 0.0055 USD | $32.92M 96K USD | 0 | -$0.03 -0.00008 USD | |
| Neovacs S.A. ALNEV.PA | $0.04 0.04 USD |
0
|
$76.37K 83.48K USD | $466.24K 509.67K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $76.37K 83.48K USD | 0 | -$37,997 -41536.07 USD | |
| U.S. Stem Cell USRM | $0.0001 — |
0
|
$64.15K — | $2K — | $0.0001 — | $0.0001 — | $64.15K — | 0 | $0 — | |
| Q BioMed QBIO | $0.0001 — |
0
|
$14.51K — | $500 — | $0.0001 — | $0.0001 — | $14.51K — | 0 | -$0.02 — | |
| Better Therapeutics BTTX | $0.0002 — |
-33.33
|
$10.9K — | $2.38K — | $0.0002 — | $0.0002 — | $10.9K — | 0 | -$1.1 — | |
| Statera Biopharma STAB | $0.0001 — |
0
|
$7.14K — | $11K — | $0.0001 — | $0.0001 — | $7.14K — | 0 | -$2.36 — | |
| Calithera Biosciences CALA | $0.001 — |
0
|
$4.87K — | $200 — | $0.0001 — | $0.0001 — | $4.87K — | 0 | -$13.23 — | |
| Molecular Templates MTEM | $0.0001 — |
0
|
$658 — | $1.57K — | $0.0001 — | $0.0001 — | $658 — | 0 | -$3.05 — | |
| NLS Pharmaceutics NLSPW | $0.002099 — |
-57.14
|
$0 — | $40.25K — | $0.002099 — | $0.004799 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $47.2 9.57 USD |
+3.96
|
$1.73T 351.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.73T 351.14B USD | 19.26 | $2.45 0.5 USD | |
| Novo Nordisk A/S NOVA.F | $58.8 64.28 USD |
+6.52
|
$240.17B 262.53B USD | $2.42K 2.65K USD | $54 59.03 USD | $59.7 65.26 USD | $240.17B 262.53B USD | 19.40 | $3.03 3.31 USD | |
| Novo Nordisk A/S NVON.MX | $1,314 77.8 USD |
+2.82
|
$3.03T 179.43B USD | $2.19K 129.5 USD | $1,256 74.37 USD | $1,314.54 77.84 USD | $3.03T 179.43B USD | 21.16 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $9,680.42 573.2 USD |
-0.83
|
$2.49T 147.64B USD | $1.54K 90.89 USD | $9,680.42 573.2 USD | $9,715.11 575.25 USD | $2.49T 147.64B USD | 0 | -$42.95 -2.5 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $704.59 142.81 USD |
-0.22
|
$724.54B 146.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $724.54B 146.85B USD | 0 | -$3.11 -0.6 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $416.2 454.96 USD |
-4.64
|
$111.27B 121.63B USD | $220 240.49 USD | $412.95 451.41 USD | $428.45 468.35 USD | $111.27B 121.63B USD | 0 | -$1.91 -2.08 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $416.3 455.07 USD |
-3.62
|
$107.23B 117.22B USD | $380 415.39 USD | $411.55 449.88 USD | $424.15 463.65 USD | $107.23B 117.22B USD | 0 | -$1.9 -2.07 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $414.7 453.32 USD |
-5.22
|
$106.61B 116.54B USD | $212 231.74 USD | $410.05 448.24 USD | $427.45 467.26 USD | $106.61B 116.54B USD | 0 | -$1.93 -2.1 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $11,544.79 683.59 USD |
+0.96
|
$1.27T 75.34B USD | $290 17.17 USD | $11,529.03 682.66 USD | $11,544.79 683.59 USD | $1.27T 75.34B USD | 14.54 | $793.61 46.99 USD | |
| CSL Limited CSJ.F | $137.1 149.87 USD |
+5.71
|
$66.39B 72.57B USD | $10 10.93 USD | $125.1 136.75 USD | $137.1 149.87 USD | $66.39B 72.57B USD | 27.64 | $4.96 5.42 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $55 11.15 USD |
0
|
$354.77B 71.91B USD | $0 0 USD | $0 0 USD | $0 0 USD | $354.77B 71.91B USD | 14.55 | $3.78 0.77 USD | |
| CSL CMXHF | $147.9 — |
+1.06
|
$71.61B — | $100 — | $147.9 — | $147.9 — | $71.61B — | 27.18 | $5.44 — | |
| CSL Limited CSJA.F | $62.5 68.32 USD |
-5.3
|
$61.35B 67.06B USD | $6 6.56 USD | $62 67.77 USD | $62.5 68.32 USD | $61.35B 67.06B USD | 25.20 | $2.48 2.71 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $485.3 530.5 USD |
-6.82
|
$55.77B 60.97B USD | $57 62.31 USD | $485.3 530.5 USD | $500 546.57 USD | $55.77B 60.97B USD | 13.81 | $35.14 38.41 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,010,000 762.38 USD |
+1.81
|
$71.89T 54.26B USD | $97.68K 73.73 USD | $998,000 753.33 USD | $1,030,000 777.48 USD | $71.89T 54.26B USD | 0 | $0 0 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| argenx SE ARGNF | $697.42 — |
0
|
$42.54B — | $5 — | $695.15 — | $695.15 — | $42.54B — | 54.65 | $12.76 — | |
| argenx SE A1RG34.SA | $133.25 27.01 USD |
0
|
$205.59B 41.67B USD | $0 0 USD | $0 0 USD | $0 0 USD | $205.59B 41.67B USD | 44.12 | $3.02 0.61 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $77.54 15.72 USD |
0
|
$200.71B 40.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $200.71B 40.68B USD | 0 | -$0.64 -0.1 USD | |
| argenx SE 1AE.F | $502.8 549.63 USD |
+0.24
|
$30.67B 33.52B USD | $7 7.65 USD | $502.8 549.63 USD | $502.8 549.63 USD | $30.67B 33.52B USD | 43.30 | $11.61 12.69 USD | |
| argenx SE ARGX.VI | $489 534.54 USD |
-6.89
|
$29.82B 32.6B USD | $0 0 USD | $489 534.54 USD | $499.4 545.91 USD | $29.82B 32.6B USD | 41.83 | $11.69 12.78 USD | |
| argenx SE 1AEA.F | $486 531.26 USD |
-2.41
|
$29.64B 32.4B USD | $1 1.09 USD | $486 531.26 USD | $486 531.26 USD | $29.64B 32.4B USD | 42.55 | $11.42 12.48 USD | |
| UCB SA UCBJF | $159.4 — |
0
|
$30.47B — | $100 — | $159.4 — | $159.4 — | $30.47B — | 26.65 | $5.98 — | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| UCB SA UNC0.F | $69.5 75.97 USD |
-4.14
|
$26.42B 28.88B USD | $50 54.66 USD | $69.5 75.97 USD | $69.5 75.97 USD | $26.42B 28.88B USD | 26.42 | $2.63 2.87 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $199.6 218.19 USD |
-6.69
|
$25.83B 28.24B USD | $172 188.02 USD | $198.7 217.21 USD | $199.6 218.19 USD | $25.83B 28.24B USD | 0 | -$1.99 -2.1 USD | |
| UCB SA UNC.F | $135.9 148.56 USD |
-7.83
|
$25.83B 28.23B USD | $100 109.31 USD | $135.9 148.56 USD | $141.85 155.06 USD | $25.83B 28.23B USD | 24.79 | $5.48 5.99 USD | |
| UCB SA UCB.VI | $132.3 144.62 USD |
-11.53
|
$25.14B 27.48B USD | $0 0 USD | $132.3 144.62 USD | $137.4 150.2 USD | $25.14B 27.48B USD | 24.14 | $5.48 5.99 USD | |
| Celltrion, Inc. 068270.KS | $163,300 123.26 USD |
+5.7
|
$35.55T 26.84B USD | $432.98K 326.83 USD | $160,000 120.77 USD | $166,000 125.3 USD | $35.55T 26.84B USD | 0 | $0 0 USD | |
| BioNTech SE B1NT34.SA | $33.99 6.89 USD |
+7.19
|
$132.1B 26.78B USD | $0 0 USD | $0 0 USD | $0 0 USD | $132.1B 26.78B USD | 0 | -$1.12 -0.2 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. 49B.F | $15.4 16.83 USD |
+6.54
|
$22.57B 24.68B USD | $500 546.57 USD | $14.65 16.01 USD | $15.4 16.83 USD | $22.57B 24.68B USD | 0 | -$0.43 -0.4 USD | |
| BeiGene, Ltd. 49BA.F | $180 196.76 USD |
-11.76
|
$22.57B 24.68B USD | $20 21.86 USD | $180 196.76 USD | $192 209.88 USD | $22.57B 24.68B USD | 0 | -$5.56 -6.07 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BioNTech SE 22UA.F | $85 92.92 USD |
+3.16
|
$20.43B 22.34B USD | $3.9K 4.26K USD | $76.15 83.24 USD | $85 92.92 USD | $20.43B 22.34B USD | 0 | -$2.86 -3.1 USD | |
| BioNTech SE BNTX.VI | $77.05 84.23 USD |
-4.88
|
$19.09B 20.86B USD | $50 54.66 USD | $77.05 84.23 USD | $78.3 85.59 USD | $19.09B 20.86B USD | 0 | -$2.77 -3.02 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $29.59 32.35 USD |
+4.6
|
$17.04B 18.63B USD | $2 2.19 USD | $27.29 29.83 USD | $29.59 32.35 USD | $17.04B 18.63B USD | 16.90 | $1.75 1.91 USD | |
| Royalty Pharma plc RPD.MU | $27.77 30.36 USD |
-2.53
|
$15.88B 17.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.88B 17.36B USD | 15.86 | $1.75 1.91 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$282.35B 16.72B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $282.35B 16.72B USD | 32.36 | $45.73 2.71 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Incyte Corporation I1NC34.SA | $209 42.36 USD |
0
|
$80.89B 16.4B USD | $0 0 USD | $209 42.36 USD | $209 42.36 USD | $80.89B 16.4B USD | 475.00 | $0.44 0.09 USD | |
| Incyte Corporation INCY.MX | $1,430.49 84.7 USD |
0
|
$276.83B 16.39B USD | $0 0 USD | $1,430.49 84.7 USD | $1,430.49 84.7 USD | $276.83B 16.39B USD | 454.12 | $3.15 0.19 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $208.72 42.3 USD |
0
|
$79.64B 16.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $79.64B 16.14B USD | 31.96 | $6.53 1.32 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Moderna, Inc. MRNA.MX | $539 31.92 USD |
+6.64
|
$210.33B 12.45B USD | $509 30.14 USD | $493 29.19 USD | $560 33.16 USD | $210.33B 12.45B USD | 0 | -$192.1 -11.3 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Insmed Incorporated IM8N.SG | $61.5 67.23 USD |
-1.6
|
$11.18B 12.22B USD | $0 0 USD | $57.5 62.86 USD | $61.5 67.23 USD | $11.18B 12.22B USD | 0 | -$5.11 -5.5 USD | |
| United Therapeutics Corporation UTH.F | $248 271.1 USD |
-7.46
|
$11.14B 12.18B USD | $20 21.86 USD | $248 271.1 USD | $248 271.1 USD | $11.14B 12.18B USD | 10.98 | $22.57 24.67 USD | |
| Genmab A/S GMAB.VI | $156.45 171.02 USD |
-7.04
|
$10.71B 11.71B USD | $0 0 USD | $156.45 171.02 USD | $161.35 176.38 USD | $10.71B 11.71B USD | 9.62 | $16.26 17.77 USD | |
| Insmed Incorporated IM8N.F | $58 63.4 USD |
-4.13
|
$10.55B 11.53B USD | $140 153.04 USD | $58 63.4 USD | $58 63.4 USD | $10.55B 11.53B USD | 0 | -$5.11 -5.5 USD | |
| Genmab A/S GNMSF | $179.65 — |
-2.67
|
$11.32B — | $1 — | $184.58 — | $184.58 — | $11.32B — | 10.13 | $17.73 — | |
| Incyte Corporation ICY.F | $51.12 55.88 USD |
-7.63
|
$9.89B 10.81B USD | $6 6.56 USD | $51.12 55.88 USD | $51.12 55.88 USD | $9.89B 10.81B USD | 365.14 | $0.14 0.15 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $48.7 53.24 USD |
-9.31
|
$9.77B 10.68B USD | $151 165.06 USD | $48.7 53.24 USD | $52.06 56.91 USD | $9.77B 10.68B USD | 23.99 | $2.03 2.22 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $49.98 54.63 USD |
-8.09
|
$9.58B 10.48B USD | $62 67.77 USD | $49.98 54.63 USD | $50.64 55.36 USD | $9.58B 10.48B USD | 24.74 | $2.02 2.21 USD | |
| Ascendis Pharma A/S A1SN34.SA | $54.36 11.02 USD |
0
|
$48.88B 9.91B USD | $0 0 USD | $0 0 USD | $0 0 USD | $48.88B 9.91B USD | 0 | -$42.17 -8.5 USD | |
| WuXi Biologics (Cayman) WXIBF | $2.42 — |
0
|
$9.88B — | $2.2K — | $3.48 — | $3.55 — | $9.88B — | 22.00 | $0.11 — | |
| Verona Pharma plc I9SA.F | $50.4 55.09 USD |
+32.63
|
$8.77B 9.59B USD | $57 62.31 USD | $50.4 55.09 USD | $50.4 55.09 USD | $8.77B 9.59B USD | 0 | -$1.98 -2.1 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $4.08 4.46 USD |
+1.49
|
$8.74B 9.55B USD | $1.76K 1.92K USD | $4.08 4.46 USD | $4.08 4.46 USD | $8.74B 9.55B USD | 20.39 | $0.2 0.22 USD | |
| Moderna, Inc. 0QF.F | $22 24.05 USD |
-3.64
|
$8.73B 9.54B USD | $200 218.63 USD | $21.51 23.51 USD | $22.59 24.69 USD | $8.73B 9.54B USD | 0 | -$8.19 -8.9 USD | |
| Moderna, Inc. MRNA.VI | $22.31 24.39 USD |
-4.39
|
$8.73B 9.54B USD | $4.22K 4.61K USD | $21.64 23.65 USD | $22.43 24.52 USD | $8.73B 9.54B USD | 0 | -$8.5 -9.2 USD | |
| Moderna, Inc. 0QF.MU | $21.84 23.87 USD |
-6.85
|
$8.73B 9.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.73B 9.54B USD | 0 | -$7.92 -8.6 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.7 1.97 USD |
-5.73
|
$46B 9.32B USD | $0 0 USD | $0 0 USD | $0 0 USD | $46B 9.32B USD | 51.05 | $0.19 0.04 USD | |
| Exelixis, Inc. EX9.F | $30.19 33 USD |
-4.85
|
$8.45B 9.24B USD | $500 546.57 USD | $30.19 33 USD | $30.19 33 USD | $8.45B 9.24B USD | 18.75 | $1.61 1.76 USD | |
| Innovent Biologics, Inc. 6IB.F | $5.1 5.57 USD |
+5.37
|
$8.3B 9.08B USD | $2K 2.19K USD | $4.76 5.2 USD | $5.1 5.57 USD | $8.3B 9.08B USD | 0 | -$0.01 -0.01 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||